Total Payments
$3,285
2022 Payments
$239.90
Companies
19
Transactions
122
Medicare Patients
1,012
Medicare Billing
$98,413
Payment Breakdown by Category
Food & Beverage$3,267 (99.4%)
Education$18.32 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,267 | 120 | 99.4% |
| Education | $18.32 | 2 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,004 | 24 | $0 (2022) |
| PFIZER INC. | $468.84 | 8 | $0 (2019) |
| Allergan Inc. | $458.71 | 21 | $0 (2019) |
| Janssen Biotech, Inc. | $338.04 | 29 | $0 (2019) |
| Janssen Scientific Affairs, LLC | $189.38 | 2 | $0 (2018) |
| Valeant Pharmaceuticals North America LLC | $143.57 | 5 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $124.88 | 1 | $0 (2021) |
| UCB, Inc. | $103.59 | 6 | $0 (2018) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $94.85 | 5 | $0 (2018) |
| Braintree Laboratories, Inc. | $81.89 | 4 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $239.90 | 2 | ABBVIE INC. ($239.90) |
| 2021 | $124.88 | 1 | E.R. Squibb & Sons, L.L.C. ($124.88) |
| 2020 | $24.31 | 2 | AbbVie Inc. ($12.20) |
| 2019 | $653.08 | 22 | PFIZER INC. ($247.00) |
| 2018 | $1,086 | 44 | AbbVie, Inc. ($229.42) |
| 2017 | $1,157 | 51 | AbbVie, Inc. ($351.83) |
All Payment Transactions
122 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/27/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $119.95 | General |
| Category: IMMUNOLOGY | ||||||
| 06/21/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $119.95 | General |
| Category: IMMUNOLOGY | ||||||
| 09/09/2021 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $124.88 | General |
| Category: Neuroscience | ||||||
| 10/13/2020 | Braintree Laboratories, Inc. | MOTOFEN (Drug) | Food and Beverage | In-kind items and services | $12.11 | General |
| Category: GASTROENTEROLOGY - DIARRHEA | ||||||
| 09/25/2020 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/17/2019 | Allergan Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $11.56 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/12/2019 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $4.16 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/22/2019 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $119.74 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/02/2019 | PFIZER INC. | INFLECTRA (Biological) | Education | In-kind items and services | $9.16 | General |
| Category: INFLAMMATION | ||||||
| 09/24/2019 | PFIZER INC. | INFLECTRA (Biological) | Education | In-kind items and services | $9.16 | General |
| Category: INFLAMMATION | ||||||
| 08/06/2019 | Allergan Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $4.29 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/16/2019 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $103.68 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 07/16/2019 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $3.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/17/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Immunology | ||||||
| 05/31/2019 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Immunology | ||||||
| 05/15/2019 | Janssen Biotech, Inc. | REMICADE (Biological), STELARA, SIMPONI | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: Immunology | ||||||
| 05/03/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: Immunology | ||||||
| 04/22/2019 | Janssen Biotech, Inc. | REMICADE (Biological), STELARA, SIMPONI | Food and Beverage | In-kind items and services | $11.18 | General |
| Category: Immunology | ||||||
| 04/18/2019 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Immunology | ||||||
| 04/08/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: Immunology | ||||||
| 04/01/2019 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: Immunology | ||||||
| 03/28/2019 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 03/27/2019 | Janssen Biotech, Inc. | REMICADE (Biological), STELARA, SIMPONI | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Immunology | ||||||
| 03/19/2019 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $3.29 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/12/2019 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $107.33 | General |
| Category: Virology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 8 | 287 | 301 | $448,315 | $27,647 |
| 2021 | 8 | 392 | 421 | $622,098 | $38,643 |
| 2020 | 8 | 333 | 363 | $491,243 | $32,123 |
Total Patients
1,012
Total Services
1,085
Medicare Billing
$98,413
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 85 | 85 | $148,567 | $7,484 | 5.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 39 | 39 | $82,267 | $7,311 | 8.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 47 | 50 | $9,450 | $4,002 | 42.4% |
| 43255 | Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 13 | 18 | $36,250 | $2,306 | 6.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 18 | 18 | $5,550 | $2,204 | 39.7% |
| 43251 | Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | Facility | 2022 | 15 | 16 | $26,080 | $1,901 | 7.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 47 | 51 | $65,361 | $1,375 | 2.1% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 23 | 24 | $74,790 | $1,064 | 1.4% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 65 | 66 | $135,169 | $12,564 | 9.3% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 105 | 107 | $180,659 | $7,419 | 4.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 51 | 57 | $13,952 | $5,267 | 37.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 35 | 35 | $13,089 | $3,915 | 29.9% |
| 43249 | Balloon dilation of esophagus, stomach and upper small bowel using a flexible endoscope | Facility | 2021 | 34 | 38 | $114,215 | $2,665 | 2.3% |
| 43251 | Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope using a mechanical snare | Facility | 2021 | 18 | 19 | $29,950 | $2,467 | 8.2% |
| 43255 | Control of bleeding of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 16 | 17 | $33,540 | $2,270 | 6.8% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 68 | 82 | $101,524 | $2,075 | 2.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope | Facility | 2020 | 32 | 34 | $66,940 | $6,663 | 10.0% |
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 73 | 75 | $121,691 | $6,355 | 5.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 34 | 34 | $9,797 | $3,907 | 39.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 52 | 56 | $10,965 | $3,762 | 34.3% |
| 43255 | Control of bleeding of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 21 | 25 | $47,437 | $3,652 | 7.7% |
| 43249 | Balloon dilation of esophagus using an endoscope | Facility | 2020 | 35 | 38 | $110,147 | $3,104 | 2.8% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 73 | 88 | $104,617 | $3,051 | 2.9% |
| 43251 | Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 13 | 13 | $19,648 | $1,629 | 8.3% |
About Dr. Gary Gerstner, M.D
Dr. Gary Gerstner, M.D is a Gastroenterology healthcare provider based in Waukesha, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1255392056.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Gerstner, M.D has received a total of $3,285 in payments from pharmaceutical and medical device companies, with $239.90 received in 2022. These payments were reported across 122 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($3,267).
As a Medicare-enrolled provider, Gerstner has provided services to 1,012 Medicare beneficiaries, totaling 1,085 services with total Medicare billing of $98,413. Data is available for 3 years (2020–2022), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Waukesha, WI
- Active Since 03/31/2006
- Last Updated 08/12/2014
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1255392056
Products in Payments
- STELARA (Biological) $387.98
- XELJANZ (Drug) $351.89
- Humira (Biological) $350.88
- LINZESS (Drug) $343.09
- Mavyret (Drug) $240.35
- XIFAXAN (Drug) $152.89
- VIBERZI (Drug) $142.62
- REMICADE (Biological) $139.44
- ZEPOSIA (Drug) $124.88
- RINVOQ (Biological) $119.95
- SKYRIZI (Biological) $119.95
- INFLECTRA (Biological) $116.95
- Cimzia (Drug) $103.59
- SUPREP (Drug) $69.78
- Trulance (Drug) $56.11
- UCERIS (Drug) $54.22
- INJECTAFER (Drug) $49.44
- Entyvio (Biological) $43.78
- CLENPIQ (Drug) $28.38
- Technivie (Drug) $22.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.